HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    

Zacks Equity Research
Zacks Rank can tell you which stocks to buy and sell. Zacks Equity Research tells you why. Click here to learn more.
Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive


AMAG: Amag Pharmaceuticals Inc - Detailed Stock Quote Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Quote |  Detailed Quotes |  Real Time |  Options Chain |  Greeks Montage
AMAG PHARMACEUTICALS INC (NASD)
AMAG 39.75 -0.06 (-0.15%) Vol.  483,665 16:00 ET
Last 39.75 Bid / Size 39.68x0
Net  -0.06 Ask / Size 40.60x0
% Change  -0.15 52 Wk High 58.23
High 40.12 52 Wk Low 22.20
Low 39.32 Volume 483,665
 
Insider Ownership 3.3% S&P 500 Member NO
Institutional Ownership % Beta 1.72
P/E (TTM) PEG Ratio
PE (forward) Price / Sales 147.55
 
Dividend N/A
Dividend Yield 0
Last Dividend Date N/A
5 Year Avg. Yield 0
Dividend Payout Ratio
 
Shares Outstanding N/A
Market Capitalization N/A
Last Split Date 09/26/1991
Split Factor 1.5
Short Interest Ratio 10
 
% Change
4 Weeks 8.22
12 Weeks -4.61
52 Weeks 44.97
 
% Change Relative to S&P 500
4 Weeks 8.37
12 Weeks -9.89
52 Weeks -.05

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research